Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Inventory: 2012-2024

Historic Inventory for Vanda Pharmaceuticals (VNDA) over the last 12 years, with Dec 2024 value amounting to $9.5 million.

  • Vanda Pharmaceuticals' Inventory rose 5.25% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 5.25%. This contributed to the annual value of $9.5 million for FY2024, which is 6.78% down from last year.
  • As of FY2024, Vanda Pharmaceuticals' Inventory stood at $9.5 million, which was down 6.78% from $10.2 million recorded in FY2023.
  • Vanda Pharmaceuticals' 5-year Inventory high stood at $11.5 million for FY2022, and its period low was $6.4 million during FY2020.
  • Its 3-year average for Inventory is $10.4 million, with a median of $10.2 million in 2023.
  • Its Inventory has fluctuated over the past 5 years, first spiked by 60.72% in 2020, then fell by 11.18% in 2023.
  • Vanda Pharmaceuticals' Inventory (Yearly) stood at $6.4 million in 2020, then increased by 29.52% to $8.3 million in 2021, then skyrocketed by 39.24% to $11.5 million in 2022, then fell by 11.18% to $10.2 million in 2023, then declined by 6.78% to $9.5 million in 2024.